My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 284

    1.

    Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem.

    Hayward RA, Hofer TP, Vijan S.

    Ann Intern Med. 2006 Oct 3;145(7):520-30. Review.PMID: 17015870 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

    J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.PMID: 15358046 [PubMed - indexed for MEDLINE]Related articles

    3.

    Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

    Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.PMID: 15297292 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

    Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763. PMID: 15249516 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.

    Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP.

    Curr Med Res Opin. 2007 Sep;23(9):2183-92.PMID: 17692154 [PubMed - indexed for MEDLINE]Related articles

    6.

    Lack of evidence for recommended low-density lipoprotein cholesterol treatment targets.

    Modest GA.

    Ann Intern Med. 2007 Apr 17;146(8):614; author reply 614-5. No abstract available. PMID: 17438326 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.

    Baessler A, Fischer M, Huf V, Mell S, Hengstenberg C, Mayer B, Holmer S, Riegger G, Schunkert H.

    Int J Cardiol. 2005 May 25;101(2):293-8.PMID: 15882678 [PubMed - indexed for MEDLINE]Related articles

    8.

    Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

    Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J.

    Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. Review.PMID: 18485273 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study.

    Paragh G, Márk L, Zámolyi K, Pados G, Ofner P.

    Clin Drug Investig. 2007;27(9):647-60.PMID: 17705573 [PubMed - indexed for MEDLINE]Related articles

    10.

    The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease.

    Ho KT, Chin KW, Ng KS, Alemao E, Rajagopalan S, Yin D.

    Am J Cardiovasc Drugs. 2006;6(6):383-91.PMID: 17192128 [PubMed - indexed for MEDLINE]Related articles

    11.

    Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.

    Robinson JG.

    Am J Cardiol. 2008 Apr 1;101(7):1009-15. Review.PMID: 18359323 [PubMed - indexed for MEDLINE]Related articles

    12.

    Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).

    LaRosa JC, Grundy SM, Kastelein JJ, Kostis JB, Greten H; Treating to New Targets (TNT) Steering Committee and Investigators.

    Am J Cardiol. 2007 Sep 1;100(5):747-52. Epub 2007 Jun 14.PMID: 17719314 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.

    Vijan S, Hayward RA; American College of Physicians.

    Ann Intern Med. 2004 Apr 20;140(8):650-8. Review.PMID: 15096337 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

    Hausenloy DJ, Yellon DM.

    Heart. 2008 Jun;94(6):706-14. Review.PMID: 18480348 [PubMed - indexed for MEDLINE]Related articles

    15.

    Lack of evidence for recommended low-density lipoprotein cholesterol treatment targets.

    Ravnskov U.

    Ann Intern Med. 2007 Apr 17;146(8):614; author reply 614-5. No abstract available. PMID: 17438325 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis.

    Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D.

    Clin Ther. 2009 Feb;31(2):236-44. Review.PMID: 19302897 [PubMed - indexed for MEDLINE]Related articles

    17.

    A critical gap between recommended and achieved LDL-cholesterol levels. Results of statin therapy in Slovakia.

    Gajdos M, Krivosikova Z, Uhliar R.

    Bratisl Lek Listy. 2007;108(9):388-92.PMID: 18225475 [PubMed - indexed for MEDLINE]Related articles

    18.

    The safety of aggressive statin therapy: how much can low-density lipoprotein cholesterol be lowered?

    Jacobson TA.

    Mayo Clin Proc. 2006 Sep;81(9):1225-31. Review.PMID: 16970219 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.

    Ballantyne CM, Raichlen JS, Cain VA.

    J Am Coll Cardiol. 2008 Aug 19;52(8):626-32.PMID: 18702965 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Clinical use of statins and cholesterol goals in patients with several cardiovascular risk factors]

    Gómez-Belda A, Rodilla E, Albert A, García L, González C, Pascual JM.

    Med Clin (Barc). 2003 Oct 25;121(14):527-31. Spanish. PMID: 14599407 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity